Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex

Wanxia Fang; Xiaofang Che; Guohui Li; Anhui Wang; Yizhe Wang; Xiaonan Shi; Kezuo Hou; Xiaojie Zhang; Xiujuan Qu; Yunpeng Liu

doi:10.1186/s13046-021-02182-4

Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex

J Exp Clin Cancer Res. 2021 Dec 7;40(1):384. doi: 10.1186/s13046-021-02182-4.

Authors

Wanxia Fang^#^{1

2

3

4}, Xiaofang Che^#^{1

2

3

4}, Guohui Li⁵, Anhui Wang^{5

6}, Yizhe Wang⁷, Xiaonan Shi^{1

2

3

4}, Kezuo Hou^{1

2

3

4}, Xiaojie Zhang^{1

2

3

4}, Xiujuan Qu^{8

9

10

11}, Yunpeng Liu^{12

13

14

15}

Affiliations

¹ Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.
² Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.
³ Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, 110001, China.
⁴ Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, 110001, China.
⁵ Laboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116024, China.
⁶ State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of Technology, Dalian, 116024, China.
⁷ Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, 110001, China.
⁸ Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China. xiujuanqu@yahoo.com.
⁹ Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China. xiujuanqu@yahoo.com.
¹⁰ Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, 110001, China. xiujuanqu@yahoo.com.
¹¹ Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, 110001, China. xiujuanqu@yahoo.com.
¹² Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China. ypliu@cmu.edu.cn.
¹³ Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China. ypliu@cmu.edu.cn.
¹⁴ Liaoning Province Clinical Research Center for Cancer, The First Hospital of China Medical University, Shenyang, 110001, China. ypliu@cmu.edu.cn.
¹⁵ Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Hospital of China Medical University, Shenyang, 110001, China. ypliu@cmu.edu.cn.

^# Contributed equally.

No abstract available

Publication types

Published Erratum